Robert M. Anglin, VP Quality & Regulatory at ROCHESTER MEDICAL CORPORATION (ROCM), sold 8,000 shares at $8.86 ($71K) on 2010-09-07, disclosed to the SEC on 2010-09-09.
Open-market sale of $71k ROCM by VP Quality & Regulatory. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.